Association between high dietary intake of the n-3 polyunsaturated fatty acid docosahexaenoic acid and reduced risk of Crohn's disease

Alimentary Pharmacology and Therapeutics

Volumn 39, Issue 8, 2014, Pages 834-842

  Chan, S S M ^a,b   Luben, R ^c   Olsen, A ^d   Tjonneland, A ^d   Kaaks, R ^e   Lindgren, S ^f   Grip, O ^f   Bergmann, M M ^g   Boeing, H ^g   Hallmans, G ^h   Karling, P ^h   Overvad, K ⁱ   Veno S K ^j   Van Schaik, F ^k   Bueno De Mesquita, B ^k,l,m   Oldenburg, B ^k   Khaw, K T ^c   Riboli, E ^m   Hart, A R ^a,b  

^a UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^b NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^e GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^f LUND UNIVERSITY HOSPITAL   (Sweden)

^g GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^h UMEÅ UNIVERSITY   (Sweden)

ⁱ AARHUS UNIVERSITY   (Denmark)

^j AALBORG UNIVERSITY HOSPITAL   (Denmark)

^k UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^l NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^m IMPERIAL COLLEGE LONDON   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; LINOLEIC ACID; LINOLENIC ACID; OLEIC ACID; VITAMIN D;

ADULT; AGED; ARTICLE; BODY MASS; CALORIC INTAKE; CONTROLLED STUDY; CROHN DISEASE; DIET SUPPLEMENTATION; FAT INTAKE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROPHYLAXIS; PROSPECTIVE STUDY; RISK REDUCTION; SMOKING;

ADULT; AGED; CASE-CONTROL STUDIES; CROHN DISEASE; DIETARY FATS; DOCOSAHEXAENOIC ACIDS; ENERGY INTAKE; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK FACTORS;

EID: 84896395415     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.12670     Document Type: Article

References (37)

1. Jostins L, Ripke S, Weersma RK, et al,. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 2012; 491: 119-24.
2. Abraham C, Cho JH,. Inflammatory bowel disease. N Engl J Med 2009; 361: 2066-78.
3. Ananthakrishnan AN,. Environmental triggers for inflammatory bowel disease. Curr Gastroenterol Rep 2013; 15: 302.
4. Fritsche K,. Fatty acids as modulators of the immune response. Annu Rev Nutr 2006; 26: 45-73.
5. Novak TE, Babcock TA, Jho DH, Helton WS, Espat NJ,. NF-kappa B inhibition by omega -3 fatty acids modulates LPS-stimulated macrophage TNF-alpha transcription. Am J Physiol Lung Cell Mol Physiol 2003; 284: L84-9.
6. Yaqoob P, Shaikh SR,. The nutritional and clinical significance of lipid rafts. Curr Opin Clin Nutr Metab Care 2010; 13: 156-66.
7. Goldman DW, Pickett WC, Goetzl EJ,. Human neutrophil chemotactic and degranulating activities of leukotriene B5 (LTB5) derived from eicosapentaenoic acid. Biochem Biophys Res Commun 1983; 117: 282-8.
8. Serhan CN, Chiang N, Van Dyke TE,. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol 2008; 8: 349-61.
9. Sakamoto N, Kono S, Wakai K, et al,. Dietary risk factors for inflammatory bowel disease: a multicenter case-control study in Japan. Inflamm Bowel Dis 2005; 11: 154-63.
10. Ananthakrishnan AN, Khalili H, Konijeti GG, et al,. Long-term intake of dietary fat and risk of ulcerative colitis and Crohn's disease. Gut 2013; PMID: 23828881[Epub ahead of print].
11. Levy BD,. Resolvin D1 and Resolvin E1 Promote the Resolution of Allergic Airway Inflammation via Shared and Distinct Molecular Counter-Regulatory Pathways. Front Immunol 2012; 3: 390.
12. Serini S, Bizzarro A, Piccioni E, et al,. EPA and DHA differentially affect in vitro inflammatory cytokine release by peripheral blood mononuclear cells from Alzheimer's patients. Curr Alzheimer Res 2012; 9: 913-23.
13. Riboli E, Hunt KJ, Slimani N, et al,. European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr 2002; 5 (6B): 1113-24.
14. Chan SS, Luben R, Olsen A, et al,. Body Mass Index and the Risk for Crohn's Disease and Ulcerative Colitis: Data From a European Prospective Cohort Study (The IBD in EPIC Study). Am J Gastroenterol 2013; 108: 575-82.
15. Kaaks R, Slimani N, Riboli E,. Pilot phase studies on the accuracy of dietary intake measurements in the EPIC project: overall evaluation of results. European Prospective Investigation into Cancer and Nutrition. Int J Epidemiol 1997; 26 (Suppl. 1): S26-36.
16. Burdge GC, Jones AE, Wootton SA,. Eicosapentaenoic and docosapentaenoic acids are the principal products of alpha-linolenic acid metabolism in young men. Br J Nutr 2002; 88: 355-63.
17. Salem N Jr, Pawlosky R, Wegher B, Hibbeln J,. In vivo conversion of linoleic acid to arachidonic acid in human adults. Prostaglandins Leukot Essent Fatty Acids 1999; 60: 407-10.
18. Bartoli R, Fernandez-Banares F, Navarro E, et al,. Effect of olive oil on early and late events of colon carcinogenesis in rats: modulation of arachidonic acid metabolism and local prostaglandin E(2) synthesis. Gut 2000; 46: 191-9.
19. Ananthakrishnan AN, Khalili H, Higuchi LM, et al,. Higher predicted vitamin D status is associated with reduced risk of Crohn's disease. Gastroenterology 2012; 142: 482-9.
20. Corey EJ, Shih C, Cashman JR,. Docosahexaenoic acid is a strong inhibitor of prostaglandin but not leukotriene biosynthesis. Proc Natl Acad Sci U S A 1983; 80: 3581-4.
21. Rao GH, Radha E, White JG,. Effect of docosahexaenoic acid (DHA) on arachidonic acid metabolism and platelet function. Biochem Biophys Res Commun 1983; 117: 549-55.
22. Samuelsson B, Dahlen SE, Lindgren JA, Rouzer CA, Serhan CN,. Leukotrienes and lipoxins: structures, biosynthesis, and biological effects. Science 1987; 237: 1171-6.
23. Hommes DW, Meenan J, de Haas M, et al,. Soluble Fc gamma receptor III (CD 16) and eicosanoid concentrations in gut lavage fluid from patients with inflammatory bowel disease: reflection of mucosal inflammation. Gut 1996; 38: 564-7.
24. Arita M, Yoshida M, Hong S, et al,. Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis. Proc Natl Acad Sci U S A 2005; 102: 7671-6.
25. Weylandt KH, Chiu CY, Gomolka B, Waechter SF, Wiedenmann B,. Omega-3 fatty acids and their lipid mediators: towards an understanding of resolvin and protectin formation. Prostaglandins Other Lipid Mediat 2012; 97: 73-82.
26. Depner CM, Philbrick KA, Jump DB,. Docosahexaenoic acid attenuates hepatic inflammation, oxidative stress, and fibrosis without decreasing hepatosteatosis in a Ldlr(-/-) mouse model of western diet-induced nonalcoholic steatohepatitis. J Nutr 2013; 143: 315-23.
27. Watanabe S, Tsuneyama K,. Eicosapentaenoic acid attenuates hepatic accumulation of cholesterol esters but aggravates liver injury and inflammation in mice fed a cholate-supplemented high-fat diet. J Toxicol Sci 2013; 38: 379-90.
28. Rodriguez-Lagunas MJ, Ferrer R, Moreno JJ,. Effect of eicosapentaenoic acid-derived prostaglandin E3 on intestinal epithelial barrier function. Prostaglandins Leukot Essent Fatty Acids 2013; 88: 339-45.
29. Tjonneland A, Overvad K, Bergmann MM, et al,. Linoleic acid, a dietary n-6 polyunsaturated fatty acid, and the aetiology of ulcerative colitis: a nested case-control study within a European prospective cohort study. Gut 2009; 58: 1606-11.
30. Belluzzi A, Brignola C, Campieri M, Pera A, Boschi S, Miglioli M,. Effect of an enteric-coated fish-oil preparation on relapses in Crohn's disease. N Engl J Med 1996; 334: 1557-60.
31. Feagan BG, Sandborn WJ, Mittmann U, et al,. Omega-3 free fatty acids for the maintenance of remission in Crohn disease: the EPIC Randomized Controlled Trials. JAMA 2008; 299: 1690-7.
32. Turner D, Zlotkin SH, Shah PS, Griffiths AM,. Omega 3 fatty acids (fish oil) for maintenance of remission in Crohn's disease. Cochrane database of systematic reviews 2009; 1: CD006320.
33. Shivananda S, Lennard-Jones J, Logan R, et al,. Incidence of inflammatory bowel disease across Europe: is there a difference between north and south Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Gut 1996; 39: 690-7.
34. Charpentier C, Salleron J, Savoye G, et al,. Natural history of elderly-onset inflammatory bowel disease: a population-based cohort study. Gut 2013; 63: 423-32.
35. Bates B, Bates C, Prentice A, Swan G, (eds). National Diet and Nutrition Survey. Headline results from Years 1 and 2 (combined) of the Rolling Programme (2008/09-2009/10). Available at: http://www.dh.gov.uk/en/ Publicationsandstatistics/Publications/PublicationsStatistics/DH-130728.
36. Bingham SA, Gill C, Welch A, et al,. Validation of dietary assessment methods in the UK arm of EPIC using weighed records, and 24-hour urinary nitrogen and potassium and serum vitamin C and carotenoids as biomarkers. Int J Epidemiol 1997; 26 (Suppl. 1): S137-51.
37. Goldbohm RA, van't Veer P, van den Brandt PA, et al,. Reproducibility of a food frequency questionnaire and stability of dietary habits determined from five annually repeated measurements. Eur J Clin Nutr 1995; 49: 420-9.